NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1508861964 MD
Verify on CMS → Mark Martinez, MD
Pulmonary Disease Physician in Salt Lake City, Utah.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
9K
Medicare Part D claims · 344 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84.3/100
▲ 1 pts above national avg 83.5 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Martinez, MD reported a CMS MIPS final score of 84.3/100 - above the 83.5 national average - and filed 8,643 Medicare Part D claims in 2024.
- 84.3/100
- MIPS score · +1 vs avg
- 9K
- Part D claims, 2024
- 83%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Martinez, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1508861964), first enumerated 06/14/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 8,643 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 84.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1508861964 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1508861964
- ENUM-LEGACY 2005
- TAX-MID 10K Pulmonary Disease
- MIPS-INLINE 84.3/100
- RX-MID 8,643
- BOOK-THIN 73 in Utah
- PHOTO-FINISH Jeffrey Harris · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Hammad Qureshi ·…
Hammad Qureshi
84.2 MIPS pts
- Martinez · this …
Martinez · this provider
84.3 MIPS pts
- Rajindar Sikand …
Rajindar Sikand
84.3 MIPS pts
- Jeffrey Harris ·…
Jeffrey Harris
84.3 MIPS pts
- Joseph Ojile · n…
Joseph Ojile
84.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Martinez, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
84 ≥ 42nd percentile 42% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Martinez, MD sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Martinez, MD writes more Part D claims than 98% of them and scores higher on MIPS quality than 46% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Mark Martinez, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Martinez, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Martinez, MD?
Near national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
8,643 6× vs specialty avg
MIPS final score
84.3/100 0.8 pts vs avg
Specialty distribution in Utah
How Pulmonary Disease Physician compares to other specialties among Utah providers
Medicare quality performance, MIPS
Mark Martinez, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 84.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1508861964 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/14/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
84.2616
Final Score
Measured-score avg: 83.5
90
Quality
27.5385
Cost
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mark Martinez, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Mark Martinez, MD is affiliated with 3 Medicare-billing facilities.
Ihc Health Services Inc
Salt Lake City, UT
Scenic Way LLC
Murray, UT
Silverton Group LLC
Salt Lake City, UT
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Mark Martinez, MD - brand share 17.0%
Pulmonary Disease Physician average
17% brand-name claims vs 83% generic, on 8,643 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
8,643
Total Claims
$693K
Total Drug Cost
344
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,664.5
- Total Day Supply
- 173,564
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $412K
- Generic Drug Cost
- $279K
- Opioid Claims
- 151 (1.7% rate)
- Antibiotic Claims
- 362
Patient Demographics
- Average Patient Age
- 70.3 years
- Avg HCC Risk Score
- 3.65
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 96, 65-74: 98, 75-84: 97, 85+: 53
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Martinez, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Atorvastatin Calcium
Atorvastatin Calcium
343 claims
- Eliquis
Eliquis
292 claims
- Gabapentin
Gabapentin
259 claims
- Trazodone Hcl
Trazodone Hcl
257 claims
- Ipratropium-Albute…
Ipratropium-Albuterol
240 claims
- Levetiracetam
Levetiracetam
238 claims
- Levothyroxine Sodium
Levothyroxine Sodium
225 claims
- Potassium Chloride
Potassium Chloride
214 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 343 |
| Eliquis Apixaban | 292 |
| Gabapentin | 259 |
| Trazodone Hcl | 257 |
| Ipratropium-Albuterol Ipratropium/Albuterol Sulfate | 240 |
| Levetiracetam | 238 |
| Levothyroxine Sodium | 225 |
| Potassium Chloride | 214 |
| Sertraline Hcl | 167 |
| Amlodipine Besylate | 166 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Mark Martinez, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Mark Martinez, MD's 8,643 claims are above the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Martinez, both outside Utah so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (84.3 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Utah
Other clinicians with the same primary specialty enrolled in Utah, drawn from the same CMS NPPES roster as Martinez.
One of 73 Pulmonary Disease Physician providers enrolled in Utah, 5 are shown here.
Dr. Alan Abdulla
MD
Ogden, UT
Dr. Jeffrey Abel
MD
Ogden, UT
Dr. Christopher Anderson
MD
South Ogden, UT
Dr. Andrew Badke
MD
Salt Lake City, UT
Dr. Haley Belt
MD
Ogden, UT
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Martinez, MD's specialty? ▼
Mark Martinez, MD specializes in Pulmonary Disease Physician and practices in Salt Lake City, Utah. Credentials: MD.
How much does Mark Martinez, MD prescribe under Medicare Part D? ▼
In 2024, Mark Martinez, MD wrote 8,643 Medicare Part D claims totaling $693K in drug costs for 344 beneficiaries.
What is Mark Martinez, MD's Medicare quality score? ▼
Mark Martinez, MD has a CMS MIPS Final Score of 84.3/100 (Quality: 90, Cost: 27.5). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Martinez, MD located? ▼
Mark Martinez, MD is located at 8 TH AVENUE AND C ST, Salt Lake City, UT, 84143. Phone: (801) 408-7100.
What is Mark Martinez, MD's NPI number? ▼
Mark Martinez, MD's National Provider Identifier (NPI) is 1508861964, issued on 06/14/2005.
Does Mark Martinez, MD prescribe more brand-name or generic drugs? ▼
Mark Martinez, MD's prescribing is 17% brand-name and 83% generic drugs by claim count, with $412K in brand drug costs.
Does Mark Martinez, MD prescribe opioids? ▼
Yes, Mark Martinez, MD had 151 opioid claims in 2024 with an opioid prescribing rate of 1.7%.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Mark Martinez, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Mark Martinez, MD's most frequently prescribed drugs include Atorvastatin Calcium, Eliquis, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Martinez, MD accept Medicare? ▼
Mark Martinez, MD appears in CMS Medicare data with 8,643 Part D claims and 344 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Martinez, MD's credentials? ▼
Mark Martinez, MD's NPI is 1508861964 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.